First Shoulder Arthroplasty Surgeries Using Stryker’s Blueprint® Mixed Reality Guidance System Completed at Mayo Clinic in Minnesota and at St. Joseph’s Health Care London in Canada
10 Janvier 2024 - 2:35PM
Business Wire
Blueprint Mixed Reality Guidance System for shoulder
arthroplasty offers surgeons a new tool to execute their
pre-operative plan using 3D imaging and operate with more precision
and consistency
Stryker (NYSE:SYK), one of the world’s leading medical
technology companies, today announced that the first shoulder
arthroplasty surgeries using Blueprint® Mixed Reality (MR) Guidance
have been successfully completed by Dr. Joaquin Sanchez-Sotelo, MD,
PhD, Consultant and Professor of Orthopedic Surgery at Mayo Clinic
in Rochester, Minn., and Dr. George Athwal at St. Joseph’s Health
Care London, Canada.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240110257454/en/
Stryker's Blueprint MR Guidance allows
surgeons and their instruments to be ‘guided’ by 3D images and
guidance widgets, which can be displayed on the patient and in the
surgeon’s line of sight without disrupting normal workflow. (Photo:
Business Wire)
“Mixed reality technology offers important benefits to
patients,” said Dr. Sanchez-Sotelo, one of the Blueprint design
surgeons. “This technology allows the surgeon to plan and execute
the surgery based on precise images of the patient’s shoulder,
thereby minimizing the risk of improper placement of the implant.
This is individualized care tailored to each patient’s
anatomy.”
Designed by a team of world-class surgeons, the Blueprint MR
Guidance System combines Stryker's innovative software with the
Microsoft HoloLens™ 2* headset, allowing the surgeon to track the
position and orientation of surgical instrumentation in the
physical environment. Blueprint MR Guidance allows surgeons and
their instruments to be ‘guided’ by 3D images and guidance widgets,
which can be displayed on the patient and in the surgeon’s line of
sight without disrupting normal workflow. The MR Guidance system
received FDA clearance in January 2023.
“The addition of Mixed Reality Guidance to our Blueprint
platform has the potential to benefit the entire shoulder
arthroplasty market – surgeons and patients alike,” said Tim
Lanier, president of Stryker’s Trauma & Extremities division.
“Now that Mixed Reality Guidance has officially entered the
operating room, our surgeons will have access to the most
innovative technology available, enabling more precise surgical
results and allowing for improved results for patients.”
Blueprint Mixed Reality OR Visualization, the previous iteration
of Stryker’s Blueprint Mixed Reality, has been used by over 50
surgeons and in more than 3,500 shoulder replacement procedures
globally. To learn more about Blueprint and Mixed Reality, visit
shoulderblueprint.com.
Stryker anticipates the completion of the first case utilizing
the Blueprint® Mixed Reality (MR) Guidance System in Europe in
February, marking a significant milestone in advancing surgical
technology globally.
About Stryker
Stryker is a global leader in medical technologies and, together
with its customers, is driven to make healthcare better. The
company offers innovative products and services in MedSurg,
Neurotechnology, Orthopaedics and Spine that help improve patient
and healthcare outcomes. Alongside its customers around the world,
Stryker impacts more than 130 million patients annually. More
information is available at www.stryker.com.
____________
Mayo Clinic has a financial interest in the technology
referenced in this press release. Mayo Clinic will use any revenue
it receives to support its not-for-profit mission in patient care,
education and research.
Dr. Joaquin Sanchez-Sotelo is a paid consultant of Stryker
Trauma and Extremities. The opinions expressed by Dr. Joaquin
Sanchez-Sotelo are those of Dr. Joaquin Sanchez-Sotelo and not
necessarily those of Stryker. Individual experiences may vary.
A surgeon must always rely on his or her own professional
clinical judgment when deciding whether to use a particular product
when treating a particular patient. Stryker does not dispense
medical advice and recommends that surgeons be trained in the use
of any product before using it in surgery.
The information presented is intended to demonstrate the breadth
of Stryker’s product offerings. A surgeon must always refer to the
package insert, product label and/or instructions for use before
using any of Stryker’s products. Products may not be available in
all markets because product availability is subject to the
regulatory and/or medical practices in individual markets. Please
contact your sales representative if you have questions about the
availability of products in your area.
Stryker Corporation or its divisions or other corporate
affiliated entities own, use or have applied for the following
trademarks or service marks: Stryker. All other trademarks are
trademarks of their respective owners or holders.
Content ID: AP-017097A Copyright © 2024 Stryker
* Used with permission from Microsoft
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240110257454/en/
Andrea Sampson President/CEO, Sampson Public Relations Group
asampson@sampsonprgroup.com 562.304.0301
Stryker (NYSE:SYK)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Stryker (NYSE:SYK)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024